Tolerance Cometh: IgG4 After Multiple-mRNA Doses

Brian Mowrey

Spike-overload finally seems to be showing a concrete effect in the repeat-injected: B Cells in two separate cohorts were found to be self-switching to IgG4 class antibodies, associated with tolerance and anti-inflammatory response, after the 3rd dose.

… Crescioli, et ak. further offer a theory that immune suppressing IgG4 will have higher affinity than immune boosting IgG1 due to having emerged from B Cells that spent more time editing their bindy-arm design (“variable region”). They will be like strong-gripped bouncers shoving the rest of the immune system out of the tumor’s door.

… We can therefor imagine that all those mRNA-transfected cells expressing spike after the 3rd or 4th dose or beyond, should any of them decide to undergo metaplasia as a result of the metabolic stimulation of the mRNA (as I suggested in October), will already have a leg up in terms of evading the immune response.

… These results would suggest that in vivo, spike protein will attract less notice from T Cells due to decoration with IgG4 antibodies. Naturally, this could lead to increased symptomatic infection, prolonged or worsened symptoms, and higher rates of post-Paxlovid rebound.

Latest articles

The Goddard Report A podcast with Dr. Stephen Malthouse on “Making Doctors... All previous outbreaks, epidemics and pandemics end when Community Immunity, NOT...
Amanuensis Variants have been one of the hallmarks of this pandemic, with...
Samuel Reinfeld et al. The COVID-19 pandemic continues to have a deleterious...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!